Research location
Würselen
Germany
Advertisement
Research activity in Würselen
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 35 trials and 36 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Würselen
35 linked trials · page 1 of 1A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerNCT06868277 · 2025-04-10 · 1 site observation
RECRUITING
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus ChemotherapyNCT03911219 · 2019-07-10 · 1 site observation
COMPLETED
Patient Preference for Pegfilgrastim (Neulasta®) Application FormsNCT03619993 · 2018-06-25 · 1 site observation
COMPLETED
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior ChemotherapyNCT03559647 · 2018-05-30 · 1 site observation
COMPLETED
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)NCT03345810 · 2017-12-14 · 1 site observation
COMPLETED
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenNCT03016312 · 2017-01-10 · 1 site observation
COMPLETED
Fear of Activity in Situations (FActS) - Study 2016NCT02898246 · 2016-11-01 · 1 site observation
COMPLETED
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or FulvestrantNCT02894398 · 2016-09-06 · 1 site observation
COMPLETED
PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLCNCT02777658 · 2016-05-26 · 1 site observation
COMPLETED
European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT02495974 · 2015-09-08 · 1 site observation
COMPLETED
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)NCT02077634 · 2014-05-01 · 1 site observation
COMPLETED
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareNCT02236637 · 2013-06-14 · 1 site observation
COMPLETED
Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) InhibitorsNCT01764321 · 2012-12-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerNCT01565083 · 2012-04-01 · 1 site observation
COMPLETED
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNCT01444456 · 2011-10-01 · 1 site observation
COMPLETED
A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)NCT01183858 · 2010-10-01 · 1 site observation
COMPLETED
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast CancerNCT01171417 · 2010-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorNCT01459653 · 2010-03-01 · 1 site observation
COMPLETED
Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal DrynessNCT03593122 · 2010-01-04 · 1 site observation
COMPLETED
Observation of Treatment With Certolizumab Pegol in Daily PracticeNCT01069419 · 2009-10-01 · 1 site observation
COMPLETED
Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or mNCT00997230 · 2009-09-01 · 1 site observation
COMPLETED
Effectiveness and Safety of Firmagon®NCT00930319 · 2009-06-01 · 1 site observation
COMPLETED
A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.NCT00754559 · 2008-08-01 · 1 site observation
COMPLETED
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerNCT00567190 · 2008-02-12 · 1 site observation
COMPLETED
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal WomenNCT00545077 · 2007-11-06 · 1 site observation
COMPLETED
A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.NCT00502840 · 2007-07-23 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 2 site observations
COMPLETED
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF InhibitorNCT02079532 · 2006-11-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.NCT00451906 · 2006-08-01 · 1 site observation
COMPLETED
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.